AzTrials
AzTrials

Tobacco Use DisorderPhase 1NCT00269009

CHERL, Connecting Primary Care Patients With Community Resources to Facilitate Behavior Change

A Phase 1 study testing CHERL in people with Tobacco Use Disorder and Alcohol Abuse, run by Great Lakes Research Into Practice Network at 3 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators want to find out if providing a Community Health Educator Referral Liaison (CHERL) helps practices help their patients change risky behaviors (tobacco use, physical inactivity, unhealthy diet, and risky drinking) by connecting patients to available services in the community or directly providing… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
CHERL
How many people
Not given
Where
3 sitesUnited States
Study dates
Jan 2006to Feb 2007
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients, clinicians, and their staff participating in this GRIN study.

Who cannot join

  • Patients, clinicians, and their staff who are not participating in this GRIN study.

Trial locations and contacts

3 sites in 1 country.

Jodi Holtrop contact

517/353-0772

United States3 sites, 3 recruiting
  • Genesys Health System

    Flint, Michigan, 48446

    Amy Thompson, 810-245-4523

    Recruiting
  • MCRC

    Grand Rapids, Michigan, 48823

    Lori Fitzpartick, 616-732-6213

    Recruiting
  • UP Health Education Corporation

    Marquette, Michigan, 49855

    Debra Weymouth, 906-225-7667

    Recruiting

Other trials in United States

About this study

The investigators want to find out if providing a Community Health Educator Referral Liaison (CHERL) helps practices help their patients change risky behaviors (tobacco use, physical inactivity, unhealthy diet, and risky drinking) by connecting patients to available services in the community or directly providing behavior change support.

Read the detailed description

What is this about? Prescription for Health (P4H) is a national initiative funded by the Robert Wood Johnson Foundation. Nine projects have been funded nationally in this second round to advance the goals of improving health behavior identification and delivery in primary care practice. Each project is conducted through a practice-based research network (PBRN). In Michigan, our PBRN is called the Great Lakes Research In Practice Network (GRIN).

What is the purpose of the CHERL project? In our study, we want to find out if providing a Community Health Educator Referral Liaison (CHERL) helps practices help their patients change risky behaviors (tobacco use, physical inactivity, unhealthy diet, and risky drinking) by connecting patients to available services in the community or directly providing behavior change support.

Primary care providers play a key roll in encouraging patients to choose healthy behaviors. However, effective behavior change requires long term follow up and support that may not be readily available within the office practice. CHERL can help provide or link to those services thus helping the healthy message promoted by the clinician to have a more powerful and lasting effect.

What is the CHERL intervention? With this funding, we will hire and train a CHERL to work with practices. The purpose of the CHERL is for him/her to help secure behavior change support for your patients either by referring to an available resource within the community or directly providing the service. This service is available to patients with or without chronic disease diagnoses (i.e, patients with diabetes, heart disease, hypertension, obesity, back pain, lung disease, or generally healthy with opportunities to change unhealthy habits).

Patients are referred to the CHERL and he/she will determine an appropriate next step for your patient - either referral to a community program or the CHERL will provide brief telephone counseling. The health care provider will receive feedback specifically on each patient referred.

In addition, some practices (consultant-enhanced) will receive additional assistance from the CHERL, as he/she serves as a consultant to the practice, helping the practice to identify systematic mechanisms for identification and referral of at risk patients to the CHERL.

Being tested
CHERL
Keywords
Tobacco use
Medical subject headings
Tobacco Use Disorder, Alcoholism, Sedentary Behavior, Tobacco Use

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CHERLBehavioural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary outcome of interest is the referral rate for any unhealthy behavior to the CHERL with the predictor variable being referral-only versus consultant-enhanced practices.

Secondary outcomes (1)
  1. Aim 2 of the study is to determine if the patients referred to the CHERL demonstrate health behavior improvements.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2005 (estimated)
  2. Study startJan 2006
  3. Study completionFeb 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Early clinical test
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
IDs, dates and publications
ClinicalTrials.gov ID
NCT00269009
Sponsor's protocol ID
61-9165
Status last verified
Sep 2006
First submitted
22 Dec 2005
Last updated
11 Jan 2007
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing CHERL in people with Tobacco Use Disorder and Alcohol Abuse, run by Great Lakes Research Into Practice Network at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jan 2007. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Annette M Sokolnicki (517/353-0772 ext. 421, annette.sokolnicki@hc.msu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary outcome of interest is the referral rate for any unhealthy behavior to the CHERL with the predictor variable being referral-only versus consultant-enhanced practices.. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2007.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in